15% of all profit
is donated to Heal Palestine and the Palestine Children's Relief Fund (PCRF)
Provotics
Home
Platform
Research
Safety
Pricing
Company
Request access
Home
Pricing
Access
Changelog
What's
changed
.
Notable updates to Provotics, newest first.
Site & access platform
June 2026
Launched the site on
provotics.ai
with a multi-page presence (Platform, Research, Safety, Pricing, Company, Docs, Notes).
Added an
invite-only access application
gated by a confidentiality agreement, with a secured admin console (approve / reject / export).
Wired email: admin notifications, applicant acknowledgments, and decision emails.
Security pass: rate limiting, honeypots, strict headers, hashed credentials, and CSV-injection-safe exports.
2.0.0
post-launch
QSAR drug-property predictors
for 10 targets (ALK, BRAF, CDK6, EGFR, ERBB2, hERG, IDH1, KRAS, MET, PIK3CA).
A new
Reflex web app
alongside the launch app.
Immune signature, MSI, and mutation imputation
added to the prediction output.
1.0.0
public launch
Whole-body
25-site RNA-seq classifier
(RF + LR + MLP + gene-attention Transformer ensemble) with calibration, conformal prediction, and novelty / OOD detection.
Tumor-vs-normal gate, molecular subtype, prognosis, ChEMBL treatment leads, and a drug-response predictor.
Clinical input pipeline, security / audit / FHIR, bias and explanation audits, deploy bundle, and docs.